SPX -0.62% VIX 6.80%
FED'S ROSENGREN SAYS ECONOMY DOESN'T LOOK LIKE IT NEEDS INTEREST-RATE CUT 
U.S. STOCKS END LOWER AS EXPECTATIONS FOR HALF-POINT RATE CUT WANE 
STOCKS HAVE TURNED NEGATIVE IN THE FINAL HOUR OF TRADING FRIDAY 
DISNEY'S LIVE-ACTION 'LION KING' SHOULD RULE THE MOVIE WORLD ON THIS HOT WEEKEND 
YOU CAN NOW BUY TRUMP-BRANDED STRAWS TO COUNTER THE 'LIBERAL' PAPER VERSIONS 
DEEP DIVE: BIG-BANK EARNINGS POINT TO NEAR-TERM PAIN AND LONG-TERM OPPORTUNITY 
CONSUMERS REMAIN UPBEAT ABOUT U.S. ECONOMY, UNIV. OF MICH. DATA SHOW 
'RELIEF' RALLY IN BOEING A KEY FACTOR IN KEEPING DOW IN POSITIVE TERRITORY 
RED ROBIN SHARES SOAR AFTER ACTIVIST-INVESTOR OFFER 
MICROSOFT HITS ALL-TIME INTRADAY HIGH AS IT JOINS BOEING IN PACING DOW ADVANCE 
Sat, Jul 20 7:01pm


BioMarin Pharmaceutical Inc [BMRN]
$81.57 1.62 (1.95%)

BMRN Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 14.79 Billion
BMRN Description

BioMarin's focus is on rare-disease therapies. Genzyme (now part of Sanofi) markets Aldurazyme through its joint venture with BioMarin, and BioMarin markets Naglazyme, Vimizim, and Brineura independently. BioMarin also markets Kuvan and Palynziq to treat the rare metabolic disorder PKU (in addition to long-standing U.S. rights, BioMarin has reacquired international rights for Kuvan and Palynziq from Merck KGaA). BioMarin has a hemophilia A gene therapy and a treatment for achondroplasia in late-stage clinical trials.


Visit Website

BMRN Earnings

EPS -0.32 P/E Ratio 0.00
Previous Earnings Thu, Apr 25, 2019
Latest Earnings Thu, Aug 1, 2019 (In 12 days)

BMRN Dividend

Yield --
Ex-Date --
Pay Date --
History --

BMRN Charts

$80.06
52 Week Range
$106.74
Dec 24, 2018
Oct 17, 2018



Symbol Price Day % YTD %
BMRN $81.57 -1.95% -3.99%

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy